Alejandra Carvajal's Net Worth

$1.5 Million

Estimate Recalculated Jul 2, 2024 03:57PM EST

Who is Alejandra Carvajal?

Alejandra Carvajal has an estimated net worth of $1.5 Million. This is based on reported shares across multiple companies, which include Mersana Therapeutics, Inc., Cerulean Pharma Inc., and MOMENTA PHARMACEUTICALS INC.

SEC CIK

Alejandra Carvajal's CIK is 0001645755

Past Insider Trading and Trends

2020 was Alejandra Carvajal's most active year for acquiring shares with 12 total transactions. Alejandra Carvajal's most active month to acquire stocks was the month of December. 2020 was Alejandra Carvajal's most active year for disposing of shares, totalling 23 transactions. Alejandra Carvajal's most active month to dispose stocks was the month of September. 2023 saw Alejandra Carvajal paying a total of $0.00 for 262,833 shares, this is the most they've acquired in one year. In 2020 Alejandra Carvajal cashed out on 409,562 shares for a total of $1,048,260.61, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mersana Therapeutics, Inc. (MRSN) Snapshot price: $3.75

SVP, Chief Legal Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+34.82%
7.08K
$2.71
-$11,872.51
27.4K
Scheduled
Jan 13 - Jan 16
Form 4
—
0
—
—
0
Sep 5
Form 4
+84.45%
9.31K
$3.89
-$15,342.16
20.33K
Apr 26 - Apr 27
Form 4
+18.47%
1.72K
$5.74
-$4,488.68
11.02K
Jan 13 - Jan 17
Form 4
∞
9.3K
$3.69
-$14,568.12
9.3K
Apr 26
Form 4
—
0
—
—
0
Jan 14
Form 4
—
0
—
—
0
Apr 26
Form 3
—
0
—
—
0
No matching records found

Cerulean Pharma Inc. (DARE) Snapshot price: $0.3497

VP, General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Aug 22
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Dec 1
Form 3
—
0
—
—
0
No matching records found

MOMENTA PHARMACEUTICALS INC No price found

Chief Legal Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-28.80K
—
—
0
Oct 1
Form 4
+4.92%
1.35K
$33.95
-$36,903.65
28.8K
Scheduled
Jul 17 - Jul 20
Form 4
+42.53%
8.19K
$35.10
-$239,066.10
27.45K
Scheduled
Jun 29 - Jun 30
Form 4
+74.86%
8.24K
$30.15
-$203,693.40
19.26K
Scheduled
Jun 11 - Jun 12
Form 4
+13.55%
1.31K
$28.97
-$32,562.28
11.01K
Scheduled
Apr 17 - Apr 20
Form 4
∞
9.7K
$29.00
-$153,758.00
9.7K
Scheduled
Mar 5 - Mar 6
Form 4
-100.00%
-6.89K
$31.54
-$217,373.68
0
Scheduled
Feb 14
Form 4
∞
6.89K
$30.03
-$93,333.24
6.89K
Scheduled
Feb 12 - Feb 13
Form 4
—
0
—
—
0
Feb 7
Form 4
-100.00%
-1.58K
$28.98
-$45,701.46
0
Scheduled
Jan 22
Form 4
∞
1.58K
$30.08
-$25,868.80
1.58K
Scheduled
Jan 17 - Jan 21
Form 4
-100.00%
-6.81K
$14.40
-$98,121.60
0
Scheduled
Oct 21
Form 4
∞
6.81K
$13.83
-$40,604.88
6.81K
Scheduled
Oct 17 - Oct 18
Form 4/A
-31.27%
-4.72K
—
—
10.38K
Apr 13
Form 4
-100.00%
-10.38K
$14.77
-$153,371.68
0
Scheduled
Apr 29
Form 4
-31.27%
-4.72K
—
—
10.38K
Apr 13
Form 4
-4.45%
-703.00
$13.10
-$9,209.30
15.11K
Scheduled
Feb 14
Form 4
+80.72%
7.06K
$12.70
-$37,312.60
15.81K
Scheduled
Feb 12 - Feb 13
Form 4
—
0
—
—
0
Feb 11
Form 4
—
0
—
—
0
Oct 17
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found